Merck halts study in light of melanoma drug's success
Merck has halted its large clinical study of Keytruda after an independent monitoring committee found that the drug met targets as a first treatment for advanced melanoma, helping to prolong survival in previously untreated patients who were fighting ...
Fortune - Tue, 24 Mar 2015 12:30

Merck says melanoma drug meets goal; study halted
Reuters - Tue, 24 Mar 2015 06:00

Melanoma Trial Halted as Pembrolizumab Bests Ipilimumab
Medscape - Tue, 24 Mar 2015 11:00

Keytruda Meets Study Goals as Advanced Melanoma Treatment, Merck Says
Wall Street Journal - Tue, 24 Mar 2015 06:18

Merck's Keytruda bests BMS' Yervoy in head-to-head melanoma trial
FiercePharma - Tue, 24 Mar 2015 08:11

Merck in $10B Buyback; Keytruda Tops Melanoma Study
Zacks.com - Thu, 26 Mar 2015 04:48



Blackwater's story on fighting melanoma
FORT MYERS, Fla. – Great singers pour their heart and soul into their shows, but one local artist is going beyond that. Dale Brown in the lead singer of Blackwater. He has been diagnosed with melanoma and will perform his very last show next week. You ...
Wink News - Fri, 27 Mar 2015 07:03



Jackie King: The lost voice of melanoma
Being so involved in the melanoma world, I meet fellow cancer patients on a too-frequent basis. More and more, these patients are not of geriatric age, but my age or younger. One such patient, Jackie King, was diagnosed in 2012 with melanoma at age 19.
Philly.com (blog) - Thu, 26 Mar 2015 06:56



Teacher determined to educate about dangers of melanoma
He is raising awareness and helping raise money for melanoma research. “Right now is the prime time before spring break and prom to educate students. The choices they make now will impact their future,” said student Haynnah Eaton. HSE students are ...
WISH-TV - Thu, 26 Mar 2015 15:41



Combined Triple Therapy Boosts Anti-Tumor Immune Response in Melanoma
Current therapeutics rely on BRAF inhibitors and/or MEK (MAPK [mitogen-activated protein kinase]) inhibitors to fight tumors, since 50% of melanoma patients harbor BRAF mutations. BRAF genes regulate the MAPK pathway, responsible for cell growth, ...
Immuno-Oncology News - Wed, 25 Mar 2015 16:03

Immunotherapy in BRAF Wild-Type Advanced Melanoma
OncLive - Wed, 25 Mar 2015 16:26

UCLA Researchers Develop Effective Triple Combination Therapy for Melanoma
Melanoma News Today - Wed, 25 Mar 2015 15:52

Research Shows Gene Removal May Aid Melanoma Treatment
Newswise — New Brunswick, N.J., March 25, 2015 – Nearly 10,000 deaths from melanoma – the deadliest of all skin cancers – occurred in the U.S. last year, according to the National Cancer Institute. And while treatment advances have been made in ...
Newswise (press release) - Wed, 25 Mar 2015 08:45



Anti-PD-1 Therapy Poised to Take the Next Step in Melanoma
The development of agents targeting the PD-1 immune checkpoint in the treatment of patients with advanced melanoma is progressing rapidly, with optimal sequencing and combinations emerging as the most pressing questions that researchers are seeking ...
OncLive - Wed, 25 Mar 2015 11:45



Inflammatory Marker Linked With Poor Prognosis in Melanoma
A new study indicated that the measurement of levels of C-reactive protein (CRP) in the blood has been found to be an independent prognostic marker for survival in patients with melanoma. Patients with the most markedly increased levels of CRP were ...
Cancer Network - Mon, 16 Mar 2015 17:56

Higher C-Reactive Protein Predicts Worse Survival in Melanoma
Cancer Therapy Advisor - Tue, 17 Mar 2015 06:35


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014